Previous studies have demonstrated the critical link between these metabolic processes and human chronic diseases including T2D and atherosclerosis and suggested FGF19 as an independent factor for T2D and coronary artery disease (13, 29). The gene discussed is FGF19; the disease is atherosclerosis.